Article Details
Retrieved on: 2022-10-20 14:42:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Brookline Capital Management restated a “buy” rating on shares of 9 Meters Biopharma in a research note on Monday, October 3rd. Oppenheimer raised ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here